Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582309 · ClinicalTrials.gov registry record · NA
Comparative Trial Between 3 Types of Insulin Infusion Protocols
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT00582309 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 151 participants.
The verdict
NCT00582309, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
Increasing evidence from observational studies in hospitalized patients with and without diabetes indicates that hyperglycemia is a predictor of poor outcome. Over the short-term, hyperglycemia can adversely affects fluid balance (through glycosuria and dehydration), impairs immunologic response to infection, and promotes inflammation and endothelial dysfunction. Blood glucose control with intensive insulin therapy in patients with acute critical illness reduces the risk of multiorgan failure and systemic infections, and decreases short- and long-term mortality . \- Hypotheses: we hypothesize that management of inpatient hyperglycemia with a computer-guided intravenous infusion protocol (Glucommander) will facilitate a smoother glycemic control with a lower rate of hypoglycemic events than treatment following a standard insulin infusion algorithm or a simple calculated infusion protocol in critically ill patients in the medical and surgical ICU.
Interventions
- PROCEDURE Glucommander-Guided Intravenous Insulin Infusion
- PROCEDURE Standard Intravenous Insulin Infusion
- PROCEDURE Simple Calculated Intravenous Insulin Infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2007-08 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582309
The ClinicalTrials.gov registry entry for NCT00582309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Glucommander-Guided Intravenous Insulin Infusion is the first listed.
NCT00582309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582309 about?
NCT00582309 is a clinical study titled "Comparative Trial Between 3 Types of Insulin Infusion Protocols". Increasing evidence from observational studies in hospitalized patients with and without diabetes indicates that hyperglycemia is a predictor of poor outcome. Over the short-term, hyperglycemia can adversely affects fluid balance (through glycosuria and dehydration), impairs immunologic response to ...
What is the current status of trial NCT00582309?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2007-08. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00582309?
The interventions under investigation include: Glucommander-Guided Intravenous Insulin Infusion (PROCEDURE), Standard Intravenous Insulin Infusion (PROCEDURE), Simple Calculated Intravenous Insulin Infusion (PROCEDURE).
Who is sponsoring clinical trial NCT00582309?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.